Member Info for BertieBassett

It's a GREAT move to (re) name the company "officially" IB ... and lose the IQAI. IQ has been battered and beaten by its awful reputation as a mismanaged and mistrusted entity.

IB has a fabulous reputation ... and I just hope that it is not tarnished in the future by the IQ board - as that would be a total disaster.

In IB I trust - in IQAI - well ....

-- BB --

The cost to submit a Breakthrough Therapy Designation request to the FDA is $237,000.

This is a fee charged by the FDA for the review of such requests.

SO why not just tell shareholders when doing a fundraise????

-- BB --

£1 a share? Really? From less than 1 pence now?

Hmmmm ...!

OK!

-- BB --

I agree Phil BUT USD200 million is before costs and the possibility of ultimate failure ...

Drug companies that have received vouchers in the past, have not necessarily hit the big time.

A predator would factor this in.

TBH - with 250 million shares in issue - 10 pence per share is what I would expect.

-- BB --

Onceaday:

Approximately 38.7% of Breakthrough Therapy Designation requests have been granted. In 2020, it was 42%.

BTD is intended to facilitate and expedite the development and review of drugs that show promise in treating serious conditions.

The decision to grant BTD is based on whether a drug for a serious condition demonstrates substantial improvement over existing treatments, and whether it addresses an unmet medical need.

A well-prepared application with strong clinical evidence is crucial for securing BTD.

The FDA's review process for BTD is rigorous.

https://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation

Cybin Inc - CYB003 - BTD in early 2024 .. sp rose by 5% (now down 50%) - so BTD does not mean "big bucks" - although its market cap is $130 million.

However, Otuska's Sibeprenlimab - Feb 2024 - saw its sp almost triple. (mcap: USD 29 billion!)

My take is IF IQAI/IB wins BTD (with Musella on board, I can see that happening) - the company will be bought out.

Simple.

But not pounds ... just pence ...

(Apple .. haha!)

-- BB --

-- BB --

I agree ... but sadly pence rather than £!!

-- BB --

Great point there, Tyke.

If current investors felt the love ... even some love ... actually, even some acknowledgement that they exist ... then they may feel inclined to buy more shares and increase the SP.

BUT if they are treated like merde month in, month out, there is never going to be any positivity ...

BUT maybe this is what TB wants ....

-- BB --

AI is interesting BUT a complete red herring.

AI - Chat GPT 4o basically uses all the information that is put out there BY the likes of IQAI, MorningStar, LSE ... so it's all factual ...

BUT interestingly:

"In October 2024, Brown sold a significant portion of his IQ-AI shares to Braveheart Investment Group, a company where he also holds a leadership position. This transaction resulted in Braveheart acquiring nearly a 30% stake in IQ-AI . While this move aligns with Brown's investment strategy, it has raised questions among shareholders regarding potential conflicts of interest and the implications for corporate governance"

"Nonetheless, the company faces ongoing financial challenges and shareholder concerns, particularly regarding governance and transparency."

"The company's cash reserves have also declined, standing at £53,500 at the end of 2024, down from £138,751 the previous year.​"

-- BB --

Cautious,

it would be worth a disasterous penny a share ... oh wait ...

-- BB --

Comedy gold ... next TB will be comparing himself to Warren Buffett or Elon Musk!!!

-- BB --

Remuneration of the highest paid director:

Emoluments and fees 100,000 Share based payment 35,270

£135,270

and that's JUST from IQAI ...

-- BB --

TB now compares IB to Apple!!!

Comedy gold:

"The directors share the frustration of shareholders with the valuation accorded the Company by the market, not least because we are also significant shareholders. "

"By way of example, in 1998 Apple Inc's share price was $0.31 (adjusted for splits). In the ensuing next 8 years, it fluctuated between $0.53 and $6.07. Today, it trades around $236 with one of the largest global market caps. This exemplifies the unpredictability of markets and the difficulty in forecasting long-term investment outcomes."

Oh dear.

-- BB --

Highlights:

Revenue grew by over 20% in 2024, reaching $959k (£750k), up from - $758k (£609k) in 2023.

· Financial results improved significantly with losses of £327k halved compared to 2023 (£624k). Without the share options' accounting treatment, losses would have reduced further to £140k. Cash burn also improved. We are expecting a modest loss this year, and expect to at least break even, or achieve a profit next year, if current trends continue.

· GE Healthcare is now a sales partner, with training for their sales and marketing teams recently completed. GEH has provided the Company with promising sales projections.

· Post-year end fundraise of £250k.

-- BB --

But the volume is SO SO SO small Tyke ...

depressing but the way with IQAI

-- BB --

And meanwhile, we pay for TB's wages through fundraisers!

Semantic?

-- BB --

Could not even put a date on the RNS!

Amateurs ...

-- BB --

Hmmm... no! But then, I do not expect to.

In reality, what is he going to say?

COVID, Ukraine, Trump, Truss, etc etc ... excuses, excuses ...

In the end, it all rests with IB.

If/when IB is sold, IQAI will receive some kind of dividend (hopefully) and will then die a slow, agonising death.

I like the fact that all the IB staff has shares in IQAI ...

Without IB, IQAI is now't.

In IB I trust, in IQAI, TB and Semantic, I do not

-- BB --

TB wouldn't do that! He's an honest, caring and thoughtful businessman.

Also, the IB Team had IQ shares ... so ... what would happen then?

-- BB --

IQAI is main ... so ...

-- BB --